🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
341 medicines starting with “F”
MedicineActive substanceLicence holderStatus
Fexofenadine Hydrochloride 120 mg Film-coated tablets
PA22871/004/002
Fexofenadine hydrochloride Azure Pharmaceuticals Ltd. Marketed
Fexofenadine hydrochloride 180 mg Film-coated Tablets
PA0688/017/002
Fexofenadine hydrochloride Chanelle Medical Unlimited Company Not marketed
Fexofenadine Hydrochloride 180 mg Film-coated tablets
PA22871/004/003
Fexofenadine hydrochloride Azure Pharmaceuticals Ltd. Marketed
Fiasp 100 units/mL FlexTouch solution for injection in pre-filled pen
EU/1/16/1160/001-006
Insulin aspart Novo Nordisk A/S
Fibrovein 0.2% Solution for Injection
PA22778/002/001
Sodium tetradecyl sulfate STD Pharmaceutical (Ireland) Limited Not marketed
Fibrovein 0.5% Solution for Injection
PA22778/002/002
Sodium tetradecyl sulfate STD Pharmaceutical (Ireland) Limited Not marketed
Fibrovein 1% Solution for Injection
PA22778/002/003
Sodium tetradecyl sulfate STD Pharmaceutical (Ireland) Limited Not marketed
Fibrovein 3% Solution for Injection
PA22778/002/004
Sodium tetradecyl sulfate STD Pharmaceutical (Ireland) Limited Not marketed
FIBRYGA 2 g powder and solvent for solution for injection/infusion
PA2219/011/002
Human fibrinogen Octapharma (IP) Not marketed
FIBRYGA, 1 g, powder and solvent for solution for injection/infusion
PA2219/011/001
Human fibrinogen Octapharma (IP) Marketed
Filgrastim Hexal 30 MU (60 MU/ml) Solution for injection or infusion
EU/1/08/496/1-4
Ep2006 (recombinant human granulocyte-colony stimulating factor) Hexal AG
Filgrastim Hexal 48 MU (96 MU/ml) Solution for injection or infusion
EU/1/08/496/5-8
Ep2006 (recombinant human granulocyte-colony stimulating factor) Hexal AG
Filspari 200 mg film-coated tablets
EU/1/23/1788/001
Sparsentan Vifor France
Filspari 400 mg film-coated tablets
EU/1/23/1788/002-003
Sparsentan Vifor France
Filsuvez
EU/1/22/1652/001-002
BETULAE CORTEX DRY EXTRACT (5-10 : 1); EXTRACTION SOLVENT: N-HEPTANE 95% (W/W) Chiesi Farmaceutici S.p.A.
Finasteride 1mg film-coated tablets
PA22753/002/001
Finasteride Careforsons Ireland Limited Marketed
Finasteride 5 mg Film-coated Tablets
PA2315/089/001
Finasteride Accord Healthcare Ireland Ltd. Marketed
Fingolimod 0.25 mg hard capsules
PA1226/017/001
FINGOLIMOD HYDROCHLORIDE Flynn Pharma Limited Not marketed
Fingolimod 0.5 mg hard capsules
PA0074/086/001
Fingolimod Rowa Pharmaceuticals Limited, Not marketed
Fingolimod 0.5 mg hard capsules
PA1226/017/002
FINGOLIMOD HYDROCHLORIDE Flynn Pharma Limited Marketed
Fingolimod Accord 0.5 mg hard capsules
EU/1/20/1450/001-006
FINGOLIMOD HYDROCHLORIDE Accord Healthcare S.L.U.
Fingolimod Bluefish 0.5 mg hard capsules
PA1436/035/001
FINGOLIMOD HYDROCHLORIDE Bluefish Pharmaceuticals AB Not marketed
Fingolimod Clonmel 0.5 mg hard capsules
PA0126/319/001
Fingolimod Clonmel Healthcare Ltd Marketed
Fingolimod Krka 0.5 mg hard capsules
PA1347/101/001
FINGOLIMOD HYDROCHLORIDE KRKA, d.d., Novo mesto Marketed
Fingolimod MSN 0.5 mg hard capsules
PA23250/007/001
Fingolimod MSN Labs Europe Limited Marketed
Fingolimod Mylan 0.5 mg hard capsules
EU/1/21/1573/001-024
FINGOLIMOD HYDROCHLORIDE Mylan Pharmaceuticals Limited
Fingolimod Rowex 0.5 mg hard capsules
PA0711/346/001
FINGOLIMOD HYDROCHLORIDE Rowex Limited, Not marketed
Fingolimod Teva 0.5 mg hard capsules
PA0436/047/001
Fingolimod Norton Waterford Marketed
Fingolimod Tillomed 0.5 mg hard capsules
PA23169/001/001
Fingolimod Tillomed Pharma GmbH Marketed
Finlee 10 mg dispersible tablets
EU/1/23/1767/001-002
Dabrafenib Mesylate Novartis Europharm Limited
Finomel Emulsion for Infusion
PA2299/044/002
Glycine, Alanine, Arginine, Histidine, Isoleucine Baxter Holding B.V. Marketed
Finomel Peri Emulsion for Infusion
PA2299/044/001
Alanine, Arginine, Glycine, Histidine, Isoleucine Baxter Holding B.V. Marketed
Finovare 20 mg/g Cream
PA23214/001/001
Fusidic acid Citrine Healthcare Limited Marketed
Fintepla 2.2 mg/ml oral solution
EU/1/20/1491/001-004
Fenfluramine hydrochloride UCB Pharma S.A.
Fintrid 5 mg film-coated tablets
PA1445/019/001
Finasteride Aurobindo Pharma (Malta) Limited Not marketed
Firazyr 30 mg solution for injection in pre-filled syringe
EU/1/08/461/001-002
Icatibant Takeda Pharmaceuticals International AG Ireland Branch
FIRDAPSE 10 mg tablets
EU/1/09/601/001
3,4-diaminopyridine phosphate SERB S.A.
Firmagon 80 mg powder and solvent for solution for injection
EU/1/08/504/001
Degarelix (as acetate) Ferring Pharmaceuticals A/S
Firmagon 120 mg powder and solvent for solution for injection
EU/1/08/504/002
Degarelix (as acetate) Ferring Pharmaceuticals A/S
Fixapost 50 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container
PA1107/014/001
Timolol, Latanoprost Laboratoires Thea Marketed
Flagyl 400mg Tablets
PA0814/003/002
Metronidazole Fidia Farmaceutici S.p.A. Marketed
Flagyl-S 200mg/5ml Oral Suspension
PA0814/003/001
Metronidazole Fidia Farmaceutici S.p.A. Marketed
Flebogamma
EU/1/07/404/1-5
Human normal immunoglobulin Instituto Grifols S.A.
Flebogamma DIF
EU/1/07/404/006-008
Human normal immunoglobulin Instituto Grifols S.A.
Flecainide 100mg Tablets
PA1986/050/002
Flecainide acetate Teva B.V. Marketed
Flecainide 50mg Tablets
PA1986/050/001
Flecainide acetate Teva B.V. Marketed
Flector Tissugel 140 mg medicated plaster
PA1104/004/001
Diclofenac epolamine IBSA Farmaceutici Italia S.r.l Marketed
Flexbumin 200 g/l solution for infusion
PA2004/002/001
Human plasma protein Baxalta Innovations GmbH Marketed
Flixabi 100 mg powder for concentrate for solution for infusion
EU/1/16/1106/001
Infliximab Samsung Bioepis NL B.V.
Flixonase Allergy Relief 50 micrograms per dose Nasal Spray
PA0678/095/001
Fluticasone propionate Haleon Ireland Limited Marketed
1 2 3 4 5 6

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.